|
業務類別
|
Medical Devices |
|
業務概覽
|
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotopeLead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. |
| 公司地址
| 2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121 |
| 電話號碼
| +1 206 676-0900 |
| 傳真號碼
| +1 509 267-3670 |
| 公司網頁
| https://www.perspectivetherapeutics.com |
| 員工數量
| 140 |
| Dr. Markus Puhlmann, M.D.,PhD |
Chief Medical Officer |
美元 489.72K |
16/04/2025 |
| Mr. Jonathan R. Hunt |
Chief Accounting Officer |
美元 447.37K |
06/01/2025 |
| Mr. Johan M. Spoor |
Director and Chief Executive Officer |
美元 619.42K |
16/04/2025 |
| Mr. Joel Sendek |
Chief Financial Officer |
-- |
04/09/2025 |
|
|
| Ms. Heidi Henson, C.P.A. |
Independent Director |
16/04/2025 |
| Ms. Lori A. Woods |
Chairman of the Board |
16/04/2025 |
| Ms. Maya Martinez-Davis |
Independent Director |
03/09/2025 |
| Mr. Robert Froman Williamson, III |
Independent Director |
16/04/2025 |
| Mr. Johan M. Spoor |
Director and Chief Executive Officer |
16/04/2025 |
| Dr. Frank Morich, M.D.,PhD |
Independent Director |
16/04/2025 |
|
|
|
|
